GeneScience Pharmaceuticals Co. Ltd. Product Forecast - 2015

1
GeneScience Pharmaceuticals Co. Ltd. Product
Pipeline Review - 2015
Published on October - 2015
2
.
Report Overview
About GeneScience Pharmaceuticals Co. Ltd.
Product Pipeline Review 2015 Global Markets
Directs, GeneScience Pharmaceuticals Co. Ltd.
Product Pipeline Review - 2015, provides an
overview of the GeneScience Pharmaceuticals Co.
Ltd. s pharmaceutical research and development
focus. This report provides comprehensive
information on the current therapeutic
developmental pipeline of GeneScience
Pharmaceuticals Co. Ltd. s, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type. It also reviews latest
updates, and featured news and press releases,
along with special features on late-stage and
discontinued projects. Global Markets Directs
report features investigational drugs from across
globe covering over 20 therapy areas and nearly
3,000 indications. The report is built using data
and information sourced from Global Markets
Directs proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/gene
science-pharmaceuticals-co-ltd-product-pipeline-re
view-2015-market
3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of GeneScience Pharmaceuticals Co.
Ltd. including business description, key
information and facts, and its locations and
subsidiaries The report reviews current pipeline
of GeneScience Pharmaceuticals Co. Ltd.s human
therapeutic division and enlists all their major
and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
GeneScience Pharmaceuticals Co. Ltd.s pipeline
products   Reasons to buy Evaluate GeneScience
Pharmaceuticals Co. Ltd.s strategic position with
total access to detailed information on its
product pipeline Assess the growth potential of
GeneScience Pharmaceuticals Co. Ltd. in its
therapy areas of focus Identify new drug targets
and therapeutic classes in the GeneScience
Pharmaceuticals Co. Ltd.s RD portfolio and
develop key strategic initiatives to reinforce
pipeline in those areas Exploit in-licensing
opportunities by identifying windows of
opportunity to fill portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of GeneScience Pharmaceuticals
  Co. Ltd. and exploit collaboration and
  partnership opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of
  GeneScience Pharmaceuticals Co. Ltd.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  GeneScience Pharmaceuticals Co. Ltd. and identify
  potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 5List of Figures 5GeneScience
Pharmaceuticals Co. Ltd. Snapshot 6GeneScience
Pharmaceuticals Co. Ltd. Overview 6Key
Information 6Key Facts 6GeneScience
Pharmaceuticals Co. Ltd. - Research and
Development Overview 7Key Therapeutic Areas
7GeneScience Pharmaceuticals Co. Ltd. -
Pipeline Review 10Pipeline Products by Stage of
Development 10Pipeline Products - Monotherapy
11Pipeline Products - Partnered Products
12Partnered Products/Combination Treatment
Modalities 13Pipeline Products - Out-Licensed
Products 14
7
Table Of Contents
Out-Licensed Products/Combination Treatment
Modalities 15GeneScience Pharmaceuticals Co.
Ltd. - Pipeline Products Glance 16GeneScience
Pharmaceuticals Co. Ltd. - Clinical Stage
Pipeline Products 16Phase II Products/Combination
Treatment Modalities 16Phase I
Products/Combination Treatment Modalities
17GeneScience Pharmaceuticals Co. Ltd. - Early
Stage Pipeline Products 18Preclinical
Products/Combination Treatment Modalities
18Discovery Products/Combination Treatment
Modalities 19GeneScience Pharmaceuticals Co.
Ltd. - Drug Profiles 20
8
Table Of Contents
CV-9103 20Product Description 20Mechanism of
Action 20RD Progress 20 CV-9104 22Product
Description 22Mechanism of Action 22RD
Progress 22   Enquiry about this report _at_
http//www.researchbeam.com/genescience-pharmaceut
icals-co-ltd-product-pipeline-review-2015-market/e
nquire-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/genescience-pharmaceut
icals-co-ltd-product-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com